败血症对骨髓介质干细胞的影响及其对造血和免疫抑制的影响
Thatiana Correa de Melo1, Suely Kunimi Kubo Ariga2, Thais Martins de Lima2
1Centre of Excellence in New Target Discovery (CENTD), Butantan Institute, São Paulo, São Paulo, Brazil.
概括
败血症会损害骨髓中酶体细胞 (BM-MSCs) 的功能,影响它们的分化和线粒体健康. 这些败血症引起的MSC变化可能会破坏骨髓平衡并影响患者的康复.
科学领域:
- 血液学
- 细胞生物学
- 免疫学
背景情况:
- 败血症通常会导致血液异常,包括贫血,白血病和血小板减少.
- 骨髓介质层细胞 (BM-MSCs) 在血液形成和免疫调节中起着至关重要的作用.
研究的目的:
- 调查败血症对 BM-MSC 的影响.
- 确定血引起的BM-MSC变化是否有助于异常的血液形成.
主要方法:
- 在假手术或败血症手术8小时后,从小鼠中分离出BM-MSC.
- 评估了BM-MSCs的扩散,多效,免疫类型,可塑性和线粒体功能.
- 在BM-MSC中分析了细胞因子和化学因子表达.
主要成果:
- 败血症导致骨质细胞分化受损,表明可塑性降低.
- 与败血症相关的BM-MSC表现出脱极化的线粒体与改变的形态.
- 在受败血症影响的BM-MSC中观察到关键细胞因子和化学因子的减少表达.
结论:
- 败血症导致BM-MSC的功能变化.
- 这些变化可能会破坏骨髓平衡.
- 损伤的BM-MSC可能会导致急性免疫反应和长期的败血症并发症.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Mesenchymal Stem Cells
5.0K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.0K
Bone Marrow Sampling and Transplants
493
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
493
Stem Cell Therapy for Tissue Regeneration
4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
Hematopoiesis
5.6K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.6K


